Call Us Now: 647.375.9987 | business.development@acanthuspharma.com
Our Story
“Welcome to APS Pharma., a tenacious innovation driven company specializing in simplifying preclinical and early clinical drug development. Established in 2021 in the suburban Toronto metropolitan area by industry professionals with a proven track record of successful introduction of new molecular entities into pre-clinical and clinical lifecycle phases. Our founders envisioned a company focused on customized synthetic and process chemistry solutions and Good Manufacturing Practices (GMP) manufacturing.”
Propelled by Success
Since our inception we have successfully executed number of process development projects to support pre-clinical and clinical development of small molecules. We have also expanded our offerings to include process development of functional excipients to facilitate gene delivery efforts of innovation driven biotechnology and Pharma companies.
Fortitude + Confidence x Acceleration = Success
Our Purpose
Mission
Our mission is to empower biotechnology and pharmaceutical companies with expert process chemistry services, delivering tailored solutions that drive the discovery and production of life-saving therapeutics.
Vision
To be a trusted partner to biotechnology and pharmaceutical industries to support the advancement of global healthcare through accelerated therapy development.
Synthesizing Success One Molecule at a Time
Why Choose Us?
The key word that we base our activities on is "custom". We consider it our responsibility as a company to commit to your requirements and support the bigger picture you have envisioned for your molecules. We do not force you to conform to our standard product offering, instead we conform to your requests.
We are a boutique firm with no tedious layers of democracy. We are agile & hold quality as one of the key components of our operations hence we are always ready to deliver value to our clients.
To be a trusted partner to biotechnology and pharmaceutical industries to support the advancement of global healthcare through accelerated therapy development.
Clinical Stage of Interest
Where we fit in the development cycle.
Working Together. Smarter and Faster.
Our Team
Stefan Wodzinski, Ph.D.
Chief Executive Officer
- Ph.D. in Organic Chemistry, University of Toronto
- 24 years industrial experience at Teva, Taro, and Apotex Pharmachem
- Broad expertise in organic chemistry, process development, scale-up, process optimization, development of regulatory framework, troubleshooting, alternate route development
- Business and finance
Jolanta Wodzinska, Ph.D.
Chief Scientific and Innovation Officer
- Ph.D. in Organic Chemistry, University of Toronto
- 24 years industrial experience at MIT, Hemosol, ApoPharma
- Broad expertise in nonclinical drug discovery
- Business development, sales, and finance